Combined evaluation of preoperative serum CEA and CA125 as an independent prognostic biomarker in patients with early-stage cervical adenocarcinoma

G Huang, R Chen, N Lu, Q Chen, W Lv… - OncoTargets and …, 2020 - Taylor & Francis
Clinical stage and histological type were based on criteria … tumor-associated antigens have
been measured in serum … elevated pretreatment levels of SCC-Ag as a prognostic factor in …

[HTML][HTML] Significance of serum CA125 level in surgically resected cervical adenocarcinoma with adverse features

N Kim, W Park, WK Cho, DS Bae, BG Kim… - Journal of …, 2021 - ncbi.nlm.nih.gov
… results regarding the impact of histology on outcomes, several … significance of both pre-treatment
SCC-Ag (range of cutoff … high-CA125 (CA 125 levels ≥50 U/mL, 22 patients) and low-…

Identifying tumor markers-stratified subtypes (CA-125/CA19-9/carcinoembryonic antigen) in cervical adenocarcinoma

Z Zhang, Y Li, Y Wu, R Bi, X Wu… - … International Journal of …, 2023 - journals.sagepub.com
tumor-marker-based classification stratified by serum CEA, CA125, and CA19-9 levels, sought
to explore the prognosis … Moreover, pretreatment CA-125, CA19-9, and CEA were found to …

Prognostic significance of pre-treatment serum c-reactive protein level in patients with adenocarcinoma of the uterine cervix

B Bodner-Adler, O Kimberger, C Schneidinger… - Anticancer …, 2016 - ar.iiarjournals.org
… , histological grade and lymph node status, elevated CRP and cancer antigen 125 levels were
… markers such as squamous cell carcinoma antigen, tissue polypeptide antigen, CEA and …

Pretreatment carcinoembryonic antigen combined with cancer antigen-125 for predicting lymph node metastasis in endometrial carcinoma: a retrospective cohort …

SY Huang, HC Fu, CH Wu, SC Wang, YC Ou… - … Research and Clinical …, 2023 - Springer
… the cost-effective tumor markers CEA and CA-125 can be used … Serum CEA levels were
analyzed using ADVIA Centaur XP … Only non-endometrioid histology, grade 3 tumors, and > 50% …

… squamous cell carcinoma antigen level and the clinicopathological features of early-stage cervical squamous cell carcinoma and the predictive value of squamous cell …

D Xu, D Wang, S Wang, Y Tian, Z Long… - … of Gynecologic Cancer, 2017 - ijgc.bmj.com
… the relationship between serum squamous cell carcinoma … -Ag level in serum may be related
to FIGO stages18Y21 or tumor … of pretreatment squamous cell carcinoma antigen level in …

[HTML][HTML] Identification and validation of serum tumor-markers based nomogram to predict the prognostic value of patients with cervical adenocarcinoma

Y Liu, L Shi, K Chen, W Ye - Current Problems in Cancer, 2022 - Elsevier
… whether pretreatment serum tumor markers were of prognostic … increased carcinoembryonic
antigen (CEA) level in serum, … Third, we did not involve histological subtypes and HPV status…

[HTML][HTML] … serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial …

JH Choi, GS Sohn, DB Chay, HB Cho… - Obstetrics & gynecology …, 2018 - ncbi.nlm.nih.gov
… The present results suggest that pretreatment CCR might … useful for screening, diagnosis,
prognosis, monitoring, staging, … of the antigen CA125, as a reliable serum tumor marker for …

[HTML][HTML] Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive …

KH Choi, SW Lee, M Yu, S Jeong… - Journal of gynecologic …, 2019 - ncbi.nlm.nih.gov
125 (CA 125) [ 7 ,8 ]. In addition, SCC-Ag … Pretreatment serum squamous cell carcinoma
antigen: a newly … The clinical value of squamous cell carcinoma antigen in cancer of the …

Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers

RC Dolscheid-Pommerich, M Keyver-Paik… - Tumor …, 2017 - journals.sagepub.com
… Elevated levels depend on histological type and disease … tumor markers such as squamous
cell carcinoma antigen (SSCA)) CEA and CA 125 for pretreatment prediction of prognosis